Short answer

FDA says it has not authorized, cleared, or approved any smartwatch or smart ring that measures or estimates blood glucose without piercing the skin. A real CGM uses a sensor under the skin and can show glucose trends through a phone, watch, or receiver. Those are not the same claim, and the difference matters because inaccurate readings can lead to wrong insulin or sulfonylurea dosing.

What counts as a real glucose measurement

Product claimWhat to verifyWhy it matters
Noninvasive glucose from a watch or ringIs there FDA authorization for that exact product and claim?FDA has warned against using these claims for glucose decisions.
CGM data on a watchIs the watch only displaying data from an inserted sensor?The watch may be a display, not the measuring device.
Wellness trend or AI scoreWhat glucose reference standard was it validated against?A trend is not the same as a medical glucose result.
Fingerstick meter or lab testIs it a validated blood glucose method with known intended use?These are the methods used to check glucose directly.

Why the warning matters

  • For people with diabetes, an inaccurate number can lead to the wrong dose of insulin or another glucose-lowering medicine.
  • CDC and NIDDK describe CGM as a diabetes tool that estimates glucose over time, not a general wellness score.
  • MedlinePlus notes that a blood glucose test measures glucose in blood directly, which is why standard testing still matters when symptoms and wearable readings disagree.
  • If the wearable says something that does not match how you feel, trust validated testing and clinical judgment over the gadget graph.

Questions before you trust it

  • Is the exact glucose claim FDA authorized for this product, not just for the company?
  • Does it actually measure glucose, or only display data from an approved CGM?
  • What population was it validated in, and does that match the user?
  • Can the company explain accuracy, lag, calibration, and failure modes?
  • What should someone do if the wearable reading conflicts with symptoms or a fingerstick?

When follow-up matters more

Follow-up matters more when the wearable reading conflicts with symptoms, when hypoglycemia or hyperglycemia is possible, or when a person with diabetes needs a real treatment decision. In those situations, a validated blood glucose test and the existing diabetes care plan matter more than the gadget graph.

What validation should look like

A glucose wearable should clearly say whether it measures glucose directly, shows CGM data, or just displays a proxy estimate. If the company cannot describe the exact validation and intended use, the device should not be used for dosing or diagnosis.

FAQ

Can a smartwatch measure glucose without piercing the skin?

Not in a way the FDA has authorized or approved for glucose monitoring. Treat that claim as unproven until the exact product and label are checked.

Is a watch that shows CGM data the same as a glucose sensor?

No. The sensor is the part under the skin. The watch or phone may just be a display.

What should I do if my wearable reading does not match my symptoms?

Use a validated blood glucose method or follow your diabetes care plan, especially if you have low- or high-glucose symptoms.

Are CGMs only for people with diabetes?

They are primarily used for diabetes care. In people without diabetes, they can be interesting feedback tools, but they are not a replacement for standard testing or medical interpretation.

Can these devices help people without diabetes?

They may help some people notice eating or exercise patterns, but A1C and blood glucose testing are still the reference points when a real health question is on the table.

Why can inaccurate glucose readings be dangerous?

Because they can prompt the wrong treatment move, including an insulin or sulfonylurea dose that lowers glucose too far.

Related guides: CGM for non-diabetics, A1C test, fasting blood test preparation, and fasting insulin testing.

Bottom line: A watch that displays CGM data is not the same as a watch that measures glucose. Treat noninvasive glucose claims as high-risk until the exact product and claim are verified.